Cystic fibrosis is one of the most common genetic disorders, causing thick mucus build-up in the lungs and other parts of the body, breathing problems, and infection. Now, researchers have developed a ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A cell-penetrating nanobody restores function in cystic fibrosis—and points to a new class ...
BOSTON--(BUSINESS WIRE)--Porosome Therapeutics, Inc. (Porosome Therapeutics) today announced the publishing of a study that brings promise for a cure to cystic fibrosis (CF). The preprint highlights ...
The development of gene editing tools, which enable the specific targeting and correction of mutations, hold the promise of allowing us to correct those mutations that cause genetic diseases. However, ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers have succeeded in developing a so-called nanobody that penetrates directly ...
A fundamental challenge for cystic fibrosis (CF) gene therapy is ensuring sufficient transduction of airway epithelial cells to achieve therapeutic correction. Gene editing is a method to permanently ...
Researchers have discovered how part of the body's immune system could better combat a leading cause of death for people with cystic fibrosis (CF). A team led by The University of Queensland's ...
The raised outlook comes as Vertex recorded higher sales in its latest quarter, up 12% from a year ago and beating Wall Street's expectations, with the company citing strength for its cystic fibrosis ...
Cystic fibrosis is one of the most common genetic disorders, causing thick mucus build-up in the lungs and other parts of the body, breathing problems, and infection. A three-drug cocktail known as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results